Trial intelligence / Profile preview

Phase IV study of topical benvitimod cream in adults with mild to moderate plaque psoriasis

CTR20212069Phase 4Completed

Sponsor
Guangdong Zhonghao Pharmaceutical
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tapinarof in plaque psoriasis, sponsored by Guangdong Zhonghao Pharmaceutical. Started Nov 2021; status: completed.

02

Drugs

tapinarof
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on CTR20212069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20212069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call